Eton Pharmaceuticals, Inc. ($ETON)
Filing Information
| Accession Number | 0001437749-26-032240 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 6, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
25,210
Total Value
$229,406.21
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Business Officer | Common Stock | โ | Oct 2, 2026 | Exercise/Conversion | 10,522 | โ | โ | 47,547 | Direct | โ | View Details | |
Chief Business Officer | Common Stock | โ | Oct 6, 2026 | Sale | 4,166 | $55.07 | $229,406.21 | 43,381 | Direct | โ | View Details | |
Chief Business Officer | Restricted Stock Units | Derivative | Oct 2, 2026 | Exercise/Conversion | 10,522 | $0.00 | $0.00 | 21,044 | Direct | โ | View Details |